Yahoo · Nov 11, 2026
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.

NASDAQ · MCK
Healthcare · Medical - Distribution
$1,062.16
Down-$22.27 (-2.05%)
Updated Nov 20, 2026, 2:12 AM
SID Score
7.3/10
Composite research score
Smart Money
57/100
Neutral
Price performance · MCK
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 19, 2026
MCK closed at $1,062.16 after 21 trading sessions, up 4.92% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 19, 2026 | $1,077.77 | $1,082.64 | $1,042.86 | $1,062.16 | 619K |
| Nov 18, 2026 | $1,083.34 | $1,092.30 | $1,073.12 | $1,084.43 | 674.53K |
| Nov 17, 2026 | $1,092.86 | $1,109.37 | $1,085.17 | $1,091.67 | 722.82K |
| Nov 16, 2026 | $1,117.98 | $1,118.01 | $1,099.70 | $1,105.04 | 900.06K |
| Nov 13, 2026 | $1,087.46 | $1,104.32 | $1,083.54 | $1,102.81 | 527.49K |
| Nov 12, 2026 | $1,090.00 | $1,090.898 | $1,074.65 | $1,077.05 | 539K |
| Nov 11, 2026 | $1,075.23 | $1,081.4725 | $1,067.375 | $1,079.79 | 474.9K |
| Nov 10, 2026 | $1,064.42 | $1,086.94 | $1,059.00 | $1,082.59 | 605.2K |
| Nov 9, 2026 | $1,067.49 | $1,069.11 | $1,055.73 | $1,059.37 | 490.69K |
| Nov 6, 2026 | $1,051.67 | $1,070.145 | $1,046.70 | $1,060.84 | 812.14K |
| Nov 5, 2026 | $1,085.84 | $1,121.50 | $1,072.00 | $1,072.00 | 1.29M |
| Nov 4, 2026 | $1,020.00 | $1,073.95 | $1,004.88 | $1,069.44 | 1.17M |
| Nov 3, 2026 | $990.89 | $1,009.36 | $983.6201 | $999.62 | 691.21K |
| Nov 2, 2026 | $995.61 | $1,008.65 | $990.3005 | $998.38 | 720.28K |
| Oct 30, 2026 | $1,006.29 | $1,016.92 | $990.2959 | $994.58 | 763.21K |
| Oct 29, 2026 | $975.00 | $982.70 | $964.77 | $980.88 | 721.49K |
| Oct 28, 2026 | $955.95 | $970.925 | $954.05 | $960.56 | 764.14K |
| Oct 27, 2026 | $989.04 | $992.8225 | $966.49 | $967.02 | 587.07K |
| Oct 26, 2026 | $1,001.39 | $1,008.60 | $988.03 | $992.87 | 508.22K |
| Oct 23, 2026 | $1,010.32 | $1,012.495 | $997.02 | $1,000.77 | 628.97K |
| Oct 22, 2026 | $1,025.62 | $1,025.62 | $1,006.07 | $1,012.34 | 629.49K |
The latest Smart Investors Daily articles mentioning MCK.
Company
Market Activity
Research & News
MCK research
Company profile and research snapshot.
McKesson Corp is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 18, 2026 | Barclays | Overweight | — |
| Nov 10, 2026 | JP Morgan | Overweight | — |
| Nov 5, 2026 | Evercore ISI Group | Outperform | — |
| Nov 5, 2026 | UBS | Buy | — |
| Nov 5, 2026 | TD Cowen | Buy | — |
No generated briefing is available yet.
Yahoo · Nov 11, 2026
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Yahoo · Nov 11, 2026
McKesson Corporation (MCK) shares up over 235% since May 2022 thanks to institutional support.
Yahoo · Nov 10, 2026
McKesson (MCK) could produce exceptional returns because of its solid growth attributes.
Benzinga · Nov 10, 2026
JP Morgan analyst Lisa Gill maintains McKesson (NYSE:MCK) with a Overweight and raises the price target from $1042 to $1255.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning MCK.